| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/04/2004 | US6730683 Such as 1-cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors |
| 05/04/2004 | US6730672 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 05/04/2004 | CA2248794C Medicament for preventive and treatment for viral infectious diseases |
| 05/04/2004 | CA2183234C Agent for prophylaxis and treatment of thromboxane a2-mediated diseases |
| 04/29/2004 | WO2004035591A1 Anthelmintic and insecticidal thiohene compositions |
| 04/29/2004 | WO2004035571A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | WO2004035569A2 Novel compounds with antibacterial activity |
| 04/29/2004 | WO2004035565A1 Method for the synthesis of a benzimidazole compound |
| 04/29/2004 | WO2004035564A1 Pyridine derivatives useful as herbicides |
| 04/29/2004 | WO2004035563A1 3-heterocyclylpyridine derivatives useful as herbicides |
| 04/29/2004 | WO2004035550A1 Novel bicyclic inhibitors of hormone sensitive lipase |
| 04/29/2004 | WO2004035549A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | WO2004035548A1 Novel compounds |
| 04/29/2004 | WO2004035545A2 Azolecarboxamide herbicides |
| 04/29/2004 | WO2004035544A1 Benzo[d]azepine derivatives for the treatment of neurological and psychiatric disorders |
| 04/29/2004 | WO2004035543A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/29/2004 | WO2004035541A1 Benzyl substituted (piperidin-4-yl) aminobenzamido derivatives as delta-opiod receptor modulators |
| 04/29/2004 | WO2004035525A1 Inhibitors of histone deacetylase |
| 04/29/2004 | WO2004034985A2 Chemical compounds |
| 04/29/2004 | WO2004034972A2 Compounds, compositions, and methods |
| 04/29/2004 | WO2004022712A3 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/29/2004 | WO2004004730A3 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders |
| 04/29/2004 | WO2003104255A3 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives as ligands for the neuropeptide y5 receptor |
| 04/29/2004 | WO2003099810A3 Radiopharmaceuticals for imaging infection and inflammation |
| 04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/29/2004 | WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 04/29/2004 | WO2003028459A8 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 04/29/2004 | WO2002102787A3 Novel sulfonic acid derivatives |
| 04/29/2004 | WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 04/29/2004 | US20040082791 Crystals of benzimidazole compounds |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082788 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 04/29/2004 | US20040082786 Piperazine based inhibitors of factor xa |
| 04/29/2004 | US20040082785 Process for making an aldehyde |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/29/2004 | US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 04/29/2004 | US20040082616 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 04/29/2004 | US20040082615 Psychological disorders; central nervous system disorders |
| 04/29/2004 | US20040082612 Analgesics, antiinflammatory agents, autoimmune diseases; central nervous system disorders, psychological disorders, drug abuse, alcoholism, cardiovascular disorders |
| 04/29/2004 | US20040082611 Novel sulfonyl derivatives |
| 04/29/2004 | US20040082610 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor |
| 04/29/2004 | US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 04/29/2004 | US20040082608 Active oxygen scavenger |
| 04/29/2004 | US20040082607 Fused heterocyclic compounds |
| 04/29/2004 | US20040082606 Excitatory amino acid receptor antagonists |
| 04/29/2004 | US20040082605 Use |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082591 Psychological disorders; antidepressants; anxiolytic agents; eating disorders; sleep disorders; gastrointestinal disorders; cardiovascular disorders |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082589 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 04/29/2004 | US20040082586 Insecticides, nematocides |
| 04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082582 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/29/2004 | US20040082581 Controlling cell proliferation; antitumor agents |
| 04/29/2004 | US20040082578 Antiinflammatory agents; Aids therapy; phosphodiesterase inhibitor |
| 04/29/2004 | US20040082577 Amino methyl imidazoles as C5a receptor modulators |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/29/2004 | US20040082572 Benzodiazepine derivatives as app modulators |
| 04/29/2004 | US20040082571 Substituted piperazines |
| 04/29/2004 | US20040082567 Antiproliferative agents; anticancer agents; fungicides; antiinflammatory agents |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082563 Thrombosis therapy; antitumor agents; anticoagulants; Factor x inhibitors; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 04/29/2004 | US20040082559 Vitronectin receptor antagonists |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin |
| 04/29/2004 | US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease |
| 04/29/2004 | US20040082475 Herbicides |
| 04/29/2004 | CA2502516A1 Anthelmintic and insecticidal thiophene compositions |
| 04/29/2004 | CA2501547A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | CA2501418A1 Novel compounds |
| 04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
| 04/29/2004 | CA2500320A1 Novel compounds with antibacterial activity |
| 04/29/2004 | CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/28/2004 | EP1413579A1 Imidazoline derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/28/2004 | EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 04/28/2004 | EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists |
| 04/28/2004 | EP1412364A1 Platelet adp receptor inhibitors |
| 04/28/2004 | EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 04/28/2004 | EP1412348A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
| 04/28/2004 | EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412333A1 Biphenyl-substituted 4-hydroxy-quinolones and their use as pesticides and herbicides |
| 04/28/2004 | EP1412331A1 Process for the production of 4-amino-2,5-bisheterocyclylquinazolines |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |